Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Lineage Cell Therapeutics, Inc. (LCTX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
8 Feb 2024
BAILEY DON M
Director
Lineage Cell Therapeutics, Inc.
(LCTX)
158,801
+153%
96,155
$1.04
$100,001.20
BUY
6 Feb 2024
BROADWOOD PARTNERS, L.P.
Director, 10% Owner
Lineage Cell Therapeutics, Inc.
(LCTX)
41,666,256
+19%
6,730,770
$1.04
$7,000,000.50
BUY
29 Dec 2023
Jayasuriya Anula
Director
Lineage Cell Therapeutics, Inc.
(LCTX)
10,000
+100%
10,000
$1.09
$10,900.00
BUY
31 Mar 2022
Culley Brian M
President and CEO, Director, Officer
Lineage Cell Therapeutics, Inc.
(LCTX)
97,787
+7%
6,400
$1.53
$9,792.00
BUY
28 Mar 2022
Amin Dipti
Director
Lineage Cell Therapeutics, Inc.
(LCTX)
35,000
+100%
35,000
$1.63
$57,050.00
BUY
25 Mar 2022
Culley Brian M
President and CEO, Director, Officer
Lineage Cell Therapeutics, Inc.
(LCTX)
81,280
+6%
5,250
$1.38
$7,245.00
BUY
24 Mar 2022
Mulroy Michael H.
Director
Lineage Cell Therapeutics, Inc.
(LCTX)
258,555
+2%
7,000
$1.40
$9,800.00
BUY
23 Mar 2022
BROADWOOD PARTNERS, L.P.
Director, 10% Owner
Lineage Cell Therapeutics, Inc.
(LCTX)
34,935,484
+2%
930,106
$1.42
$1,317,666.80
SELL
28 Dec 2021
Hogge Gary S.
SVP,Clinical & Medical Affairs, Officer
Lineage Cell Therapeutics, Inc.
(LCTX)
28,445
-94%
539,283
$2.45
$1,321,328.90
SELL
29 Jun 2021
ANDREWS DEBORAH J
Director
Lineage Cell Therapeutics, Inc.
(LCTX)
15,578
-55%
19,142
$2.93
$56,086.06
SELL
29 Jun 2021
Russell Angus C.
Director
Lineage Cell Therapeutics, Inc.
(LCTX)
87,500
-5%
4,720
$2.97
$14,018.40
SELL
28 Jun 2021
Culley Brian M
President and CEO, Director, Officer
Lineage Cell Therapeutics, Inc.
(LCTX)
45,709
-90%
450,000
$2.87
$1,291,500.00
SELL
15 Mar 2021
Hernandez Alexandra
Sr Director Finance/Controller, Officer
Lineage Cell Therapeutics, Inc.
(LCTX)
0
-100%
6,000
$2.23
$13,380.00
BUY
13 Aug 2019
BROADWOOD PARTNERS, L.P.
Director, 10% Owner
Lineage Cell Therapeutics, Inc.
(LCTX)
34,005,380
+0%
24,553
$0.98
$24,045.30
BUY
13 Aug 2019
Roberts Brandi
CFO & SVP, Finance, Officer
Lineage Cell Therapeutics, Inc.
(LCTX)
5,000
+100%
5,000
$1.01
$5,050.00
BUY
13 Aug 2019
Culley Brian M
President and CEO, Director, Officer
Lineage Cell Therapeutics, Inc.
(LCTX)
84,531
+13%
10,000
$1.01
$10,100.00
BUY
31 Jul 2019
Leavitt Chase C.
General Counsel/Secretary, Officer
Lineage Cell Therapeutics, Inc.
(LCTX)
5,000
+100%
5,000
$1.02
$5,100.00
BUY
11 Sep 2018
ANDREWS DEBORAH J
Director
BIOTIME INC
(BTX)
10,000
+19%
1,604
$2.35
$3,769.40
BUY
13 Oct 2017
BROADWOOD PARTNERS, L.P.
Director, 10% Owner
BIOTIME INC
(BTX)
29,971,560
+9%
2,692,307
$2.60
$6,999,998.00
BUY
23 Aug 2017
SKIBSTED RUSSELL
Chief Financial Officer, Officer
BIOTIME INC
(BTX)
2,000
+100%
2,000
$2.64
$5,284.80
BUY
22 Aug 2017
BROADWOOD PARTNERS, L.P.
Director, 10% Owner
BIOTIME INC
(BTX)
27,279,254
+0%
10,000
$2.60
$25,955.00
BUY
22 Aug 2017
WEST MICHAEL D
Co-Chief Executive Officer, Director, Officer
BIOTIME INC
(BTX)
882,864
+0%
2,000
$2.60
$5,198.00
BUY
21 Aug 2017
MOHANTY ADITYA P.
Co-Chief Executive Officer, Director, Officer
BIOTIME INC
(BTX)
89,696
+9%
7,500
$2.50
$18,750.00
BUY
21 Aug 2017
ANDREWS DEBORAH J
Director
BIOTIME INC
(BTX)
8,396
+39%
2,396
$2.50
$5,990.00
BUY
21 Aug 2017
Patton Stephana Eilene
General Counsel, Officer
BIOTIME INC
(BTX)
7,500
+100%
7,500
$2.58
$19,376.25
BUY
31 Jul 2017
BROADWOOD PARTNERS, L.P.
Director, 10% Owner
BIOTIME INC
(BTX)
27,269,254
+0%
150,000
$2.80
$420,000.00
SELL
31 Jul 2017
KINGSLEY ALFRED D
See Remarks, Director, Officer
BIOTIME INC
(BTX)
5,781,555
-2%
150,000
$2.80
$420,000.00
BUY
16 Jun 2017
ANDREWS DEBORAH J
Director
BIOTIME INC
(BTX)
6,000
+50%
2,000
$2.95
$5,900.00
BUY
16 May 2017
ANDREWS DEBORAH J
Director
BIOTIME INC
(BTX)
4,000
+100%
2,000
$3.21
$6,410.40
BUY
15 Feb 2017
BROADWOOD PARTNERS, L.P.
Director, 10% Owner
BIOTIME INC
(BTX)
27,119,254
+8%
2,222,222
$2.70
$5,999,999.50
BUY
21 Jun 2016
BROADWOOD PARTNERS LP
Director, 10% Owner
BIOTIME INC
(BTX)
24,897,032
+12%
2,732,636
$2.39
$6,531,000.50
BUY
20 Jan 2016
BROADWOOD PARTNERS LP
Director, 10% Owner
BIOTIME INC
(BTX)
22,164,396
+1%
300,000
$2.35
$705,000.00
SELL
20 Jan 2016
KINGSLEY ALFRED D
See Remarks, Director, Officer, 10% Owner
BIOTIME INC
(BTX)
5,638,055
-5%
300,000
$2.35
$705,000.00
Home